These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1993328)

  • 1. Practical method for optimizing radioimmunoassay detection and precision limits.
    Ezan E; Tiberghien C; Dray F
    Clin Chem; 1991 Feb; 37(2):226-30. PubMed ID: 1993328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple and complex antibody reactions in radioimmunoassay and the prediction of assay characteristics.
    Willey KP
    J Immunol Methods; 1985 Nov; 84(1-2):343-58. PubMed ID: 4067320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A computerized method for optimization of radioimmunoassays].
    Rousseau F; Forest JC
    Ann Biol Clin (Paris); 1990; 48(5):297-302. PubMed ID: 2368936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dependence of radioimmunoassay detection limits on antibody affinity.
    O'Connor T; Gosling JP
    J Immunol Methods; 1997 Oct; 208(2):181-9. PubMed ID: 9433473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of undesired cross-reactants by using mixtures of antibodies: experimental and theoretical evaluations of hapten radioimmunoassays.
    Boutten B; Ezan E; Mamas S; Dray F
    Clin Chem; 1991 Mar; 37(3):394-7. PubMed ID: 2004446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical modelling of competitive labelled-ligand assay systems. Theoretical re-evaluation of optimum assay conditions and precision data for some experimentally established radioimmunoassay systems.
    Keilacker H; Besch W; Woltanski KP; Diaz-Alonso JM; Kohnert KD; Ziegler M
    Eur J Clin Chem Clin Biochem; 1991 Sep; 29(9):555-63. PubMed ID: 1760485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer program for evaluation, physicochemical characterization and optimization of competitive protein binding assays: comparison of four curve-fitting models in peptide and steroid radioimmunoassays.
    Schöneshöfer M
    Clin Chim Acta; 1977 Jun; 77(2):101-15. PubMed ID: 890938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of radioimmunoassay data: a computer program for curvefitting and dose interpolation using orthogonal polynomials.
    Nemoz C; Faure A; Bizzollon C; Site J
    Comput Programs Biomed; 1978 Jun; 8(2):99-109. PubMed ID: 668312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation of the Müller method to allow quantitative characterization of the affinity and cross-reactivity of antibodies by competitive radioimmunoassay.
    Winzor DJ; Bowles MR; Pentel PR; Schoof DD; Pond SM
    Mol Immunol; 1991 Sep; 28(9):995-1001. PubMed ID: 1922113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of the equilibrium constant for an antibody using data derived from an antiserum dilution curve.
    Roulston JE
    J Immunol Methods; 1983 Sep; 63(1):133-8. PubMed ID: 6619549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal statistical design of radioimmunoassays and competitive protein-binding assays.
    Chang PC; Rubin RT; Yu M
    Endocrinology; 1975 Apr; 96(4):973-81. PubMed ID: 1120486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunological determination of fenoterol. Part II: Antiserum and tracer for the determination of fenoterol.
    Rominger KL; Mentrup A; Stiasni M
    Arzneimittelforschung; 1990 Aug; 40(8):887-95. PubMed ID: 2242081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of antiserum avidity on inhibition reactions.
    Tosi RM; Celada F
    Immunology; 1974 Nov; 27(5):941-51. PubMed ID: 4435840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulation model for predicting limit of detection and range of quantitation of competitive enzyme-linked immunosorbent assay.
    Choi DH; Katakura Y; Matsuda R; Hayashi Y; Ninomiya K; Shioya S
    J Biosci Bioeng; 2007 May; 103(5):427-31. PubMed ID: 17609157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of radioligand binding and radioimmuno assays.
    Junghans RP
    Anal Biochem; 1996 Aug; 240(1):75-89. PubMed ID: 8811882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new mathematical model for fitting an HPL radioimmunoassay curve.
    Harding BR; Thomson R; Curtis AR
    J Clin Pathol; 1973 Dec; 26(12):973-6. PubMed ID: 4784505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graphical determination of specific activity, binding constants, and antibody-site concentrations for radioimmunoassays, with application to thymopoietin.
    Verhoff FH; Lisi PJ; Fischer CD; Teipel JW; Goldstein G; Schiffman MB
    Clin Chem; 1980 May; 26(6):718-23. PubMed ID: 7371149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated data processing and radioassays.
    Samols E; Barrows GH
    Semin Nucl Med; 1978 Apr; 8(2):163-79. PubMed ID: 684443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assessment of antibody affinity from radioimmunoassay.
    Berzofsky JA
    Clin Chem; 1978 Mar; 24(3):419-21. PubMed ID: 630702
    [No Abstract]   [Full Text] [Related]  

  • 20. Radioimmunoassay of neocarzinostatin, an antitumor protein.
    Samy TS; Raso V
    Cancer Res; 1976 Dec; 36(12):4378-81. PubMed ID: 63321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.